Next steps for new Alzheimer’s treatment Approved this month in the US, Alzheimer’s disease treatment lecanemab is yet to undergo the regulatory approval process in Australia.
New Alzheimer’s medication found to slow cognitive decline The drug may be available as early as 2023, but there are still hurdles to cross, write Bernadette McGuinness and Elizabeth Coulthard.